文献速递慢性肾脏病急性肾损伤

前脑啡肽预测CKD患者肾功能及主要不良肾脏事件

Proenkephalin predicts kidney function and major adverse kidney events in CKD.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该研究在三个大型队列(总N=4722)中横断面分析血清前脑啡肽(PENK)与肾脏及心血管代谢标志物的关系,并在Leipzig-CKD队列中纵向评估其与4P-MAKE的关联。结果显示PENK与肾功能标志物强负相关,eGFR是最强独立反向预测因子;基线PENK与中位随访8.7年的4P-MAKE风险强相关,PENK翻倍对应4P-MAKE风险增加逾2倍。

要点

  • PENK与eGFR、肌酐及尿白蛋白肌酐比强相关,eGFR是最强独立反向预测因子。
  • 基线PENK翻倍与4P-MAKE风险增加逾2倍相关,校正临床代谢变量后仍显著。
  • PENK对识别不良肾脏结局风险患者具有附加独立预后价值。

核心结论

  • PENK水平在横断面分析中与肾功能强、独立且反向相关。
  • 基线PENK可预测CKD患者4P-MAKE,并提供附加独立预后价值。

研究设计与样本

  • 横断面分析纳入三个大型队列,总N=4722,包括Leipzig-CKD(N=581)、LIFE-Adult(N=3093)和Sorbs(N=1048)。
  • 在Leipzig-CKD队列进行纵向分析,评估基线PENK与4P-MAKE复合终点的关联。
  • 4P-MAKE包括新发或恶化肾脏病、需肾脏替代治疗或肾移植的肾衰竭及肾脏死亡。

主要发现

  • 全横断面队列(N=4722)中PENK与eGFR、肌酐及尿白蛋白肌酐比强且反向相关。
  • 多变量分析中,校正年龄、性别及肥胖、糖耐量异常、血脂异常和炎症标志物后,eGFR是最强独立反向预测因子。
  • 多变量Cox回归显示基线PENK与4P-MAKE风险增加强相关,中位随访8.7年。
  • PENK每翻倍与4P-MAKE风险增加逾2倍相关,校正多种临床代谢变量后仍显著。
  • PENK为预测不良肾脏结局提供附加价值。

临床怎么用

  • 可考虑将血清PENK作为CKD患者不良肾脏结局风险的附加预后标志物。
  • PENK升高提示肾功能受损及4P-MAKE风险增加,可辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: The endogenous opioid proenkephalin (PENK) has been identified as an independent risk marker for acute cardiovascular diseases and acute kidney injury. However, its regulation, its association with other cardiometabolic markers and its prognostic role in patients with chronic kidney disease (CKD) have not been thoroughly investigated. METHODS: PENK serum levels were cross-sectionally related to renal and cardiometabolic markers across three large cohorts (total N = 4722), including the Leipzig-CKD cohort (N = 581), as well as the population-based LIFE-Adult (N = 3093) and Sorbs (N = 1048) cohort. Furthermore, a longitudinal analysis was performed in the Leipzig-CKD cohort to assess the association between circulating PENK levels at baseline and a composite 4-point major adverse renal events (4P-MAKE) endpoint comprising incident or worsening kidney disease, development of kidney failure (KF) requiring kidney replacement therapy or kidney transplantation, and renal deaths. RESULTS: In the entire cross-sectional cohort (N = 4722), PENK levels were strongly and inversely correlated with markers of renal function, i.e. estimated glomerular filtration rate (eGFR), creatinine and urinary albumin-creatinine ratio. In multivariable analysis, eGFR was the strongest, independent and inverse predictor of circulating PENK levels after adjustment for age and sex, as well as markers of obesity, glucose intolerance, dyslipidemia and inflammation. Multivariable Cox regression analysis revealed that baseline circulating PENK levels were strongly associated with an increased risk of the 4P-MAKE over a median follow-up of 8.7 years. Each doubling of PENK levels was associated with a >2-fold increase in the risk of developing 4P-MAKE, even after adjusting for various clinical and metabolic variables. PENK provided added value for predicting adverse renal outcomes. CONCLUSIONS: PENK levels are strongly, independently, and inversely associated with renal function in cross-sectional analysis. Furthermore, baseline circulating PENK levels are predictive of a 4P-MAKE in patients and added independent, prognostic value for identification of patients at risk for adverse renal outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Würfel M, Pirlich L, Baratashvili E, et al. Proenkephalin predicts kidney function and major adverse kidney events in CKD. Nephrol Dial Transplant. 2026. PMID: 41105147. doi:10.1093/ndt/gfaf214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。